← Back to Search

Focus Groups for Human Immunodeficiency Virus Infection

N/A
Waitlist Available
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 9 months
Awards & highlights

Study Summary

This trial aims to understand experiences unique to transgender men who have sex with men and how they affect HIV risk.

Eligible Conditions
  • Human Immunodeficiency Virus Infection
  • Transgender

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post-hoc thematic analysis across five domains

Trial Design

1Treatment groups
Experimental Treatment
Group I: Focus GroupsExperimental Treatment1 Intervention
Focus groups will occur during the course of the study period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transgender men's perspectives on HIV risk and HIV prevention interventions
2022
N/A
~40

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
917,193 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities to participate in the research endeavor?

"As per the information on clinicaltrials.gov, this medical trial has suspended its search for participants as of May 17th 2023. It was originally posted on November 1st 2022 and has since ceased recruitment efforts. However, there are 476 other studies that are actively recruiting patients at present."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Transgender Men's Perspectives on HIV Risk and HIV Prevention Interventions
Ricky Hill 2022. "Transgender Men's Perspectives on HIV Risk and HIV Prevention Interventions". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05666102.
~16 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top